$Recursion Pharmaceuticals (RXRX.US)$
prospectus of secondary offering resolves two key areas in 4-6 quarters with funds coveing potentially dozensof clinical trials as well as acquisitions.
In May, Recursion also stated that they have future partnerships as well as current partners whose trials include non-dilutive funding as these clical trials progress.
Increased my stake by 15%

$Recursion Pharmaceuticals (RXRX.US)$
Interesting that Nvidia owns 3.6% of RXRX and ARK owns 10%. One year ago $NVIDIA (NVDA.US)$ bought 7.7M shares at $6.50 for $50M and now One Year later RXRX has prices an offering at the same price so I‘d wonder IF NVIDIA just became a 10% shareholder in Recursion and who else added to their stakes!

$Recursion Pharmaceuticals (RXRX.US)$
Recursion set to update 2024 Download Day Event with four hours of R&D content. Heres a link as well as last years Download Day for a hint of whats going on today/tonight!
🔗- YouTube Download Day Event in entirety.

$Recursion Pharmaceuticals (RXRX.US)$
for reference (see news article on update) and YouTube Jan 2024 demo here - YouTube

$Recursion Pharmaceuticals (RXRX.US)$
Seven Clinical Trial Readouts expected within approximately 18 months with dozens more incoming 😁

$Recursion Pharmaceuticals (RXRX.US)$ Love the concept as there are literally only three or so companies in this space with Recursion having the most candidates in the shortest time as welll as the fatest ramp toward fastest supercomputer on earth.
what aold me is one of their three major partners stating they DO NOT anticipate any AI acquisitions due to further ramp of Recursion in their BioHive 2 and the ability to piggyback on the future of ...

$Fisker (FSRNQ.US)$ interesting

$Recursion Pharmaceuticals (RXRX.US)$
interesting times in Artificial Intelligence within the BioPharma space as $Recursion Pharmaceuticals (RXRX.US)$ keeps expanding BioHive 2.0 with the likes of $Rivian Automotive (RIVN.US)$
Lets Go 😎